Molecular Pharmacology
Elsevier Inc.
United States
journal
SJR by Edition
Subject Categories
- PharmacologyQ1
- Molecular MedicineQ2
Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
1521-0111, 0026-895X
SJR Best Quartile
Q1
Region
Northern America
Citations per Document (2 years)
2.93
References per Document
58.07
Coverage
1965-2026
Scope
Molecular Pharmacology welcomes original reports of technically robust and scientifically sound research providing new insights into molecular mechanisms relevant to pharmacology, pharmaceutical sciences, and drug discovery across therapeutic modalities. Examples include studies of drug-receptor interactions, the impact of receptor function on cell or system physiology, receptor-linked intra- or intercellular signaling systems, enzyme or transporter function, drug delivery, drug metabolism, pharmacogenomics, ion channel function, transcriptional mechanisms, molecular mechanisms underlying disease, mechanisms of agonism, antagonism, allosteric modulation, and signaling bias. Work focused on the major receptor types (GPCRs, receptor tyrosine kinases, nuclear receptors, etc.) and ion channels, for example, are encouraged. Manuscripts that identify novel drug targets, approaches to treat disease or protect tissues from damage, mechanisms of action for xenobiotics, or insights into toxicologic mechanisms are also welcome, as are studies that report the development of novel reagents or technologies that are of broad applicability or yield new molecular insights. Reports that include translational studies, relevant to any of the molecular topics mentioned above, are also encouraged. Studies involving molecular or mathematical modeling relevant to drug design or drug action will also be considered if they include new experimental data or test existing experimental data to support the model(s). The journal welcomes minireview articles addressing timely issues in the field of molecular pharmacology.
Metrics from SCImago Journal Rank 2025. View on SCImago